ARCHIVES

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

This article is from The Cancer Letter archive.

Vol. 18 No. 23 | June 5, 1992

Download PDF Visit The Full Archive

Related Articles

Options For Changes, Some Drastic, In Cooperative Groups Suggested By CTEP

April 11, 1986

Science Policy: NI DOD Begins Project For Common Coding Of Cancer Grants

April 2, 1999

PET Tracer Drug Approved, Developed At Weill Cornell

September 24, 2004

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

Bonner to Succeed Stovall as NCCS President and CEO.

May 30, 2008

Avastin Vote Puts Focus On FDA Criteria In First-Line Metastatic Breast Cancer: Is PFS Good Enough?

December 14, 2007